Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
公司代码PRE
公司名称Prenetics Global Ltd
上市日期Jul 06, 2021
CEOKwok (Samantha)
员工数量285
证券类型Ordinary Share
年结日Jul 06
公司地址Unit 703-706, K11 Atelier King's Road, 728 King's Road, Quarry Bay
城市
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Hong Kong
邮编- -
电话85222109588
网址https://ir.prenetics.com/
公司代码PRE
上市日期Jul 06, 2021
CEOKwok (Samantha)